AI assistant
Sending…
PLUS THERAPEUTICS, INC. — Director's Dealing 2025
Feb 20, 2025
34301_dirs_2025-02-20_c7ea5916-2d34-4c21-aaca-2aeed5c54edf.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: PLUS THERAPEUTICS, INC. (PSTV)
CIK: 0001095981
Period of Report: 2025-02-18
Reporting Person: Sims Andrew John Hugh MacIntyre (N/A)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2025-02-18 | Stock Option (Right to Buy) | $1.18 | A | 60020 | Acquired | 2035-02-17 | Common Stock (60020) | Direct |
Footnotes
F1: (1) The option vest over four years in equal 1/48th increments on each monthly anniversary of the issuance.
More from PLUS THERAPEUTICS, INC.
Capital/Financing Update
2026
Jun 5
Regulatory Filings
2026
Jun 5
Capital/Financing Update
2026
Jun 1
Declaration of Voting Results & Voting Rights Announcements
2026
May 15
Interim / Quarterly Report
2026
May 15
Regulatory Filings
2026
May 15
Regulatory Filings
2026
Apr 21
Board/Management Information
2026
Apr 9
Regulatory Filings
2026
Apr 8
Board/Management Information
2026
Mar 26